The loss of Olig2, an oligodendrocyte marker, is a well-described histopathologic finding of H3.3-G34R/V mutant gliomas [68,90], although focal positivity in co-occurring reactive glial cells has been described [74]. The gene discussed is OLIG2; the disease is central nervous system cancer.